Last updated: April 20, 2025
Sponsor: Kholoud Usama
Overall Status: Active - Recruiting
Phase
3
Condition
Breast Cancer
Cancer
Treatment
Unilateral Erector Spinae group
Unilateral Serratus Anterior group
Clinical Study ID
NCT06947330
FMASU-MD66/2025
Ages 21-65 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
ASA Physical Status II, or III.
Age 21 - 65 years.
Female gender
Exclusion
Exclusion Criteria:
ASA IV, V, VI.
Infection at site of block.
Coagulopathy, or patients on antiplatelets, or anticoagulants.
Previous anesthetic allergy to bupivacaine.
Distant organ metastasis.
Male gender.
Study Design
Total Participants: 100
Treatment Group(s): 2
Primary Treatment: Unilateral Erector Spinae group
Phase: 3
Study Start date:
March 03, 2025
Estimated Completion Date:
March 04, 2026
Study Description
Connect with a study center
Faculty of Medicine, Ain-Shams University
Cairo, Waili 0000
EgyptActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.